HOME >> BIOLOGY >> NEWS
Fulbright awards Senior Specialist grant to Carnegie's Marilyn Fogel

Washington, DC-- As part of its international scientific exchange effort, the Fulbright Senior Specialists Program has awarded Carnegie scientist Marilyn Fogel a grant to share the most up-to-date findings in the fields of astrobiology and biogeochemistry with staff and students at the Physics of Geological Processes, University of Oslo, Norway. The Fulbright Senior Specialists Program provides two-to six-week opportunities for leading U.S. scholars to collaborate with scholars in non-U.S. post-secondary academic institutions. Fogel will give lectures, participate in workshops, and take part in fieldwork in association with the Arctic Mars Analogue Svalbard Expedition (AMASE)* this summer.

AMASE is an interdisciplinary, international team, which is designing devices and techniques for finding life on Mars. The test ground is Svalbard, a Norwegian island in the far north with a geology that is analogous to some Martian geology.

Fogel will lecture on astrobiology, an interdisciplinary field that probes the processes that led to life on this planet and explores whether it exists elsewhere. In her research, she looks at distinctive isotopes of carbon, oxygen, and nitrogen to trace phenomena ranging from the role of humans in altering the landscape in ancient Australia, to the nature of microorganisms that first populated the Earth.

"This Fulbright grant is the first of its kind for Carnegie," commented Carnegie president Richard Meserve. "We are very pleased with this award because it will help to maintain the strong linkage that has been established between Carnegie and Norwegian scientists."

Fogel has been a staff scientist at the Carnegie Institution's Geophysical Laboratory since 1979. Her undergraduate, graduate, and postgraduate research has spanned the spectrum of biology, chemistry, and geology. She graduated with a B.S. in biology from Pennsylvania State University with honors and went on to get her Ph.D. at the Univer
'"/>

Contact: Marilyn Fogel
m.fogel@Gl.ciw.edu
202-478-8981
Carnegie Institution
24-Jul-2006


Page: 1 2

Related biology news :

1. Fulbright faculty
2. NJIT mathematician receives Fulbright to study thin film science in Argentina
3. New Jersey Institute of Technology environmentalist receives Fulbright Chair award
4. Argonne wins three R&D 100 awards for innovative technologies
5. ASBMB taps 8 scientists and 1 politician for top awards
6. 2007 EURYI: 20 young researchers to receive Nobel Prize-sized awards for breakthrough ideas
7. US Department of Defense awards $1.6 million for implantable biochip research
8. 20 Kentucky firms share $1.9 million from state to match federal SBIR-STTR awards
9. The Cancer Genome Atlas awards funds for technology development
10. NIH awards nearly $21 million to fund cutting-edge research equipment
11. SNM presents awards on Capitol Hill

Post Your Comments:
(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
(Date:10/17/2014)... release is available in German . ... of sperms every day in order to reproduce? And why ... the topic of the latest issue of the research journal ... The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld has ... is not unusual for a female to copulate with several ...
(Date:10/17/2014)... To date, antidotes ... doctors are often limited to supportive therapy such as induced ... of drugs involved. So what can be done if a ... professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences at ... "The task was to develop an agent that could eliminate ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
(Date:10/22/2014)... Oct. 22, 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, announced today that ... Notice of Allowance for a composition of matter patent ... difficile program, SYN-004. This is Synthetic Biologics, first ... U.S. and adds to the Company,s extensive C. ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... 20, 2014 Asterias Biotherapeutics, Inc. (NYSE ... signed a Notice of Grant Award (NGA) with ... October 1, 2014.  The NGA provides for the ... release of additional grant funds pursuant to the ... clinical development of Asterias, product, AST-OPC1. The grant ...
(Date:10/20/2014)... BOSTON , Oct. 20, 2014 ... commercialization company tackling big healthcare problems, announced today ... investment round, with participation from Invesco Perpetual, a ... be used to drive PureTech,s existing pipeline forward ... technologies. "PureTech has the scientific creativity to really ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
Cached News: